SCHEMBL7350353

SCHEMBL7350353

C=CCNc1ccc(C(=O)O)c(O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.49
PKM P14618 1/20 0.49
MCL1 Q07820 2/20 0.47
BCL2L1 Q07817 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
ALDH1A1 P00352 5/20 0.46
TSHR P16473 1/20 0.46
CA7 P43166 1/20 0.46
CA14 Q9ULX7 1/20 0.46
STAT3 P40763 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.45
SIRT5 Q9NXA8 1/20 0.45
KDM4E B2RXH2 3/20 0.45
MEN1 O00255 2/20 0.45
GAA P10253 2/20 0.45
HSD17B10 Q99714 2/20 0.45
TDP1 Q9NUW8 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11409380 0.80 HCAR3 (0.43) KMT2ACA12CA1CA2CA9
SCHEMBL7523237 0.79 MCL1 (0.46) KMT2APKMMCL1BCL2L1CA12
SCHEMBL155359 0.78 KMT2A (0.53) KMT2APKMMCL1BCL2L1CA12
SCHEMBL20999134 0.78 BCL2L1 (0.53) KMT2APKMMCL1BCL2L1CA12
SCHEMBL7530660 0.77 KDM4C (0.54) KMT2APKMMCL1BCL2L1ALDH1A1
SCHEMBL5961640 0.76 BCL2L1 (0.52) KMT2APKMMCL1BCL2L1CA12
SCHEMBL10832661 0.76 CA12 (0.45) CA12CA1CA2CA9ALDH1A1
SCHEMBL9617447 0.76 HCAR3 (0.58) KMT2ACA12CA1CA2CA9
SCHEMBL2347257 0.75 KMT2A (0.58) KMT2APKMCA12CA1CA2
SCHEMBL12862656 0.75 BCL2L1 (0.58) KMT2APKMMCL1BCL2L1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5246942-A Central nervous system, anti-emetic and gastric prokinetic activity RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1993-09-21 US disclosed
EP-0494140-A4 DIBENZOFURANCARBOXAMIDES 1992-09-02 EP disclosed
EP-0494140-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (HOLDINGS), INC. (US) 1992-07-15 EP disclosed
WO-1991004738-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (HOLDINGS), INC. (US) 1991-04-18 WO disclosed
US-4959485-A 5-HT3 ANTAGONISTS RORER PHARMACEUTICAL CORPORATION (US) 1990-09-25 US disclosed
WO-1989010364-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-11-02 WO disclosed
EP-0339950-A2 Dibenzofurancarboxamides, their use as pharmaceutical agents, a composition containing the same, and a process for the preparation thereof RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1989-11-02 EP disclosed
US-4863921-A Dibenzofurancarboxamides and their pharmaceutical compositions and methods RORER PHARMACEUTICAL CORPORATION (US) 1989-09-05 US disclosed